| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 16.86B | 16.03B | 14.80B | 14.20B | 11.74B | 10.79B |
| Gross Profit | 2.54B | 6.94B | 6.40B | 2.06B | 1.64B | 1.39B |
| EBITDA | 3.22B | 3.15B | 2.68B | 2.88B | 2.12B | 1.94B |
| Net Income | 1.71B | 1.66B | 1.31B | 1.22B | 1.03B | 576.00M |
Balance Sheet | ||||||
| Total Assets | 36.08B | 39.85B | 36.72B | 35.90B | 32.85B | 30.16B |
| Cash, Cash Equivalents and Short-Term Investments | 2.21B | 3.82B | 4.25B | 4.62B | 3.66B | 3.70B |
| Total Debt | 5.46B | 5.17B | 5.54B | 6.17B | 5.72B | 6.65B |
| Total Liabilities | 26.48B | 28.82B | 26.97B | 26.30B | 24.29B | 23.00B |
| Stockholders Equity | 9.63B | 11.06B | 9.79B | 9.63B | 8.59B | 7.18B |
Cash Flow | ||||||
| Free Cash Flow | 2.11B | 2.06B | 1.87B | 2.20B | 1.57B | 2.69B |
| Operating Cash Flow | 2.34B | 2.30B | 2.05B | 2.40B | 1.71B | 2.85B |
| Investing Cash Flow | -1.36B | -1.12B | -348.00M | -752.00M | -419.00M | -319.00M |
| Financing Cash Flow | -1.60B | -2.01B | -1.75B | -980.00M | -1.58B | -1.86B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | €75.67M | 14.20 | 4.71% | 6.05% | -21.70% | -49.75% | |
76 Outperform | €94.98M | 18.77 | ― | ― | 21.20% | 13.12% | |
73 Outperform | €21.59B | 12.62 | 17.51% | 4.13% | 9.88% | 16.84% | |
72 Outperform | €3.25B | 13.53 | 11.69% | 3.62% | 5.80% | -9.84% | |
71 Outperform | €96.41M | 3.90 | 12.60% | 1.12% | -3.53% | 28.87% | |
61 Neutral | €39.69M | 10.91 | ― | 5.00% | 11.03% | -37.78% | |
55 Neutral | $13.29B | 17.42 | 10.03% | 0.93% | 7.13% | -12.93% |